FDA Delays Final OK for Type 2 Drug Empagliflozin
The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at
Read more
Fda
FDA Backtracks Over GLP-1s’ Effects on Pancreas
The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a
Read more
More Than 180 New Diabetes Drugs in Development
A total of 182 new drugs to treat diabetes or diabetes-related conditions are currently in clinical trials or undergoing review
Read more
FDA Approves Dexcom G4 Platinum CGM Use for Children 2-17
The U.S. Food and Drug Administration has approved the expanded use of the Dexcom G4 Platinum Continuous Glucose Monitoring System
Read more
FDA Proposes Separate Guidelines for Home vs. Clinical Glucose Meters
The Food and Drug Administration is proposing separate guidelines for over-the-counter blood glucose meters compared to those used at the
Read more
Type 1 Drug Wins Orphan Status
DV-100, a drug designed to halt the body’s autoimmune attack on pancreatic beta cells that leads to type 1 disease,
Read more
FDA Opens Way for Diabetic Macular Edema Device
The Food and Drug Adminsitration, reversing itself on a decision it made in October, has opened the way for a
Read more
Is High Fructose Corn Syrup “the New Trans Fat”?
The non-profit consumer action group Citizens for Health earlier this month called on the Food and Drug Administration to do
Read more
FDA Clears Novo’s Kid-Friendly Insulin Pen
The U.S. Food and Drug Administration has granted 510(k) clearance for the NovoPen Echo®, the first insulin injection device on
Read more
FDA Tells 15 Companies to Stop Illegal Diabetes Treatment Sales
The U.S. Food and Drug Administration has announced that it has issued letters warning 15 U.S. and foreign companies to
Read more
FDA Approves Invokana, a New Type 2 Drug
A new, first-in-its-class drug for type 2 diabetes has just been approved by the Food and Drug Administration. Invokana works
Read more